Navigation Links
Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052)
Date:5/12/2011

WASHINGTON, May 12, 2011 /PRNewswire-USNewswire/ -- Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners through initiation of oral antiretroviral therapy (ART), according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network (HPTN), a global partnership dedicated to reducing the transmission of HIV through cutting-edge biomedical, behavioral, and structural interventions.

The study, known as HPTN 052, was designed to evaluate whether immediate versus delayed use of ART by HIV-infected individuals would reduce transmission of HIV to their HIV-uninfected partners and potentially benefit the HIV-infected individual as well. Findings from the study were reviewed by an independent Data and Safety Monitoring Board (DSMB).The DSMB recommended that the results be released as soon as possible and that the findings be shared with study participants and investigators. The DSMB concluded that initiation of ART by HIV-infected individuals substantially protected their HIV-uninfected sexual partners from acquiring HIV infection, with a 96 percent reduction in risk of HIV transmission. HPTN 052 is the first randomized clinical trial to show that treating an HIV-infected individual with ART can reduce the risk of sexual transmission of HIV to an uninfected partner.

"This is excellent news," said Dr. Myron Cohen, HPTN 052 Principal Investigator and Associate Vice Chancellor for Global Health and Director of the Institute of Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill. "The study was designed to evaluate the benefit to the sexual partner as well as the benefit to the HIV-infected person. This is the first randomized clinical trial to definitively indicate that an HIV-infected individual can reduce sexual transmission of HIV to an uninfected partner by beginning antiretroviral therapy sooner. HPTN recognizes the significant contr
'/>"/>

SOURCE HIV Prevention Trials Network
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals Obeticholic Acid (INT-747) in NASH
2. Genus Oncology, LLC Announces Initiation of Phase I Trial of GO-203-2c in Patients With Solid Tumors
3. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
4. Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
5. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
6. Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist
7. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
8. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
9. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
10. Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™
11. Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  TeamHealth Medical Call Center (THMCC), a premier ... lines, announces its newly formed Clinical Advisory Committee. ... leaders, provides clinical expertise to advance THMCC,s purpose ... hospital clients, physician clients and patients. ... imperative to continuously advance our services and improve ...
(Date:5/23/2013)... 2013 Anthem Blue Cross patients with HIV/AIDS ... them to obtain their medications by mail order under ... Kallas LLC.  The lawsuit, filed in ... Cross,s mandatory mail order program announced late last year ... "This settlement brings to a close a ...
(Date:5/23/2013)... -- Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative ... that it has initiated dosing in a Phase I ... therapy for the treatment of HCV infection. This study will ... to assess both the safety and antiviral efficacy of ... the treatment of chronic HCV infections and is based ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... Big ideas are coming out of the small, island nation ... Intelligence Unit says for a country of its size, New ... "New Zealanders are known for their ingenuity—especially in ... that push the envelope," says Marta Mager, Regional Director Americas ...
... KANSAS CITY, Mo., Sept. 22, 2011 /PRNewswire/ -- ... benefits administrator, today announced an arrangement with Walmart to ... efforts by Argus and Walmart to provide the lowest ... agreement enables Argus to offer their customers a more ...
Cached Medicine Technology:Cool New Zealand Inventions 2Cool New Zealand Inventions 3Argus Announces Retail Network Relationship 2
(Date:5/25/2013)... 2013 Radius Engineering International Inc., ... in the US and has been building concrete, ... 35 years. M.E. and President, Walton McCarthy, author ... Weapon Fundamentals and Shelter Engineering Standards, Sixth Edition, ... shelter engineering. McCarthy is considered the leading expert ...
(Date:5/25/2013)... New York (PRWEB) May 25, 2013 ... allegedly suffered serious, life-threatening episodes of internal bleeding while using ... underway in U.S. District Court, Southern District of Illinois, Bernstein ... Court’s website, 818 Pradaxa side effect claims had been ... That’s up from 705 claims reported by the Court ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office to ... Most people would naturally assume that the company ... service and support would own and maintain all the ... be wrong. Cloud providers lease space in a ... houses servers and related equipment to run cloud environments) ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 IBISWorld estimates that ... at an average annual rate of 28.7% to $1.0 billion ... in 2013. From 2002 and 2008, no new cell therapy ... causing relatively modest growth during that period. In the years ... six new products. This factor contributed to the industry's fast ...
(Date:5/25/2013)... Superior Magnetics for Pain Free Living announced ... arthritis, tendinitis and bursitis , Pain Free Living - ... a magnetic bracelet so strong it relieves ... is demonstrated at fairs and festivals. This new magnetic ... has customers often report pain relief in seconds. , ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2
... rates of cessation, study found, , , WEDNESDAY, Feb. 11 (HealthDay ... them to stop their unhealthy habit helps more people give ... the Feb. 12 issue of the New England Journal ... Co. employees across the country who were offered up to ...
... 11 St. Mary-Corwin Medical Center joins Centura ... observe Heart Month throughout the month of February. ... consumer promotions to provide southern Colorado communities with ... the leading cause of death among Coloradans.Centura has ...
... of Registered Nurses Down from 2005 ProjectionsHARRISBURG, Pa., Feb. ... is shrinking, in part, because of the efforts of ... & Industry acting Secretary Sandi Vito announced today. The ... " The Registered Nurse Workforce in Pennsylvania " and ...
... following was released today by AARP Pennsylvania: WHO: ... Senator Arlene Specter. WHAT: Participants will express their ... families, businesses, and communities. And, they will hear from ... America,s health care problems under a new Administration and ...
... identified a new biological marker present in the urine ... cancer is progressing and spreading. , In experiments reported ... Nature, the scientists identified 10 metabolites that ... Their studies showed that one of these chemicals, sarcosine, ...
... say they feel unprepared for long-term care and do ... prepare for their futures, according to a survey released ... conducted by StrategyOne on behalf of AHIP, found that ... and 1980 feel somewhat or entirely unprepared for long-term ...
Cached Medicine News:Health News:Promise of Cash Prompts Smokers to Quit 2Health News:Promise of Cash Prompts Smokers to Quit 3Health News:St. Mary-Corwin Medical Center and Centura Health Celebrate Heart Month 2Health News:St. Mary-Corwin Medical Center and Centura Health Celebrate Heart Month 3Health News:Work of PA Center for Health Careers Eases Pennsylvania's Nursing Shortage 2Health News:Survey of metabolites finds new prostate cancer marker 2Health News:Survey of metabolites finds new prostate cancer marker 3Health News:Generation-X Feels Unprepared for Long-Term Care Costs and the Future, Survey Finds 2Health News:Generation-X Feels Unprepared for Long-Term Care Costs and the Future, Survey Finds 3
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
Medicine Products: